Page 12 - 《中国药房》2026年10期
P. 12

静脉制剂外配处方闭环管理模式构建与探索
                                                                              Δ


                *
                                                                                     #
          谢旭华 ,伍 云,黄松清,黄煜堃,陈思妍,曾 铮,唐微艳,何佐隆,周春霞,张宏亮(广西医科大学第一附属医
          院药学部,南宁 530021)


          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2026)10-1246-05
          DOI  10.6039/j.issn.1001-0408.2026.10.02


          摘   要  目的  构建静脉制剂外配处方全流程闭环管理模式,为静脉制剂外配处方规范化管理提供参考。方法  基于我院前期牵
          头制定的《静脉制剂外配处方闭环管理广西专家共识》,通过多学科团队头脑风暴法与鱼骨图框架,系统识别全流程风险点,制定
          并实施限定外配合作药店与药品目录、运维医院信息系统和静脉用药调配中心(PIVAS)智能管理平台、强化全链条人员差异化培
          训等策略,构建以PIVAS为核心枢纽、日间化疗中心为安全终端的全流程闭环管理体系。结果  共遴选出3家合作药店及涵盖35
          个品规的首期药品目录,成功构建了涵盖医院门诊开药、患者药店购药、PIVAS配药和日间化疗中心用药四大模块的闭环管理流
          程,实现了静脉制剂外配处方与院内溶媒的强制关联成组、药品追溯码的全程核验、输注参数的智能监测与全流程数据追溯。
          结论  所构建的模式有效解决了静脉外配药品从院外流转至院内使用的衔接与安全管控问题,初步实现了流程的标准化、信息的
          可追溯化与用药风险的主动防控。
          关键词  静脉制剂外配处方;静脉用药调配中心;闭环管理;日间化疗;双通道政策


          Development  and  exploration  of  a  closed-loop  management  model  for  externally  dispensed  intravenous
          prescriptions
          XIE Xuhua,WU Yun,HUANG Songqing,HUANG Yukun,CHEN Siyan,ZENG Zheng,TANG Weiyan,HE
          Zuolong,ZHOU Chunxia,ZHANG Hongliang(Dept.  of  Pharmacy,  the  First  Affiliated  Hospital  of  Guangxi
          Medical University, Nanning 530021, China)

          ABSTRACT    OBJECTIVE To construct a closed-loop management model for externally dispensed intravenous prescriptions, and

          to  provide  reference  for  standardized  management  of  externally  dispensed  intravenous  prescriptions.  METHODS  Based  on  the
          Expert  Consensus  on  Closed-loop  Management  of  Externally  Dispensed  Intravenous  Prescriptions  in  Guangxi  Zhuang  Autonomous
          Region  previously  formulated  by  our  hospital,  risk  points  during  the  entire  process  were  systematically  identified  through
          multidisciplinary team brainstorming and a fishbone diagram. A series of strategies were subsequently formulated and implemented,
          including  qualifying  designated  external  dispensing  pharmacies  and  the  drug  catalogs,  operating  and  maintaining  the  hospital
          information system  and  the Pharmacy Intravenous Admixture Service (PIVAS)  intelligent  management  platform,  and  strengthening
          differentiated  training  for  staff  in  the  whole  workflow.  A  whole-process  closed-loop  management  system  was  constructed  with
          PIVAS as the core hub and the daytime chemotherapy center as the safety terminal. RESULTS A total of 3 cooperating pharmacies
          and an initial drug list comprising 35 product specifications were selected. A closed‑loop management process encompassing hospital
          outpatient  prescribing,  patient  drug  purchase  in  designated  pharmacies,  PIVAS  drug  dispensing,  and  medication  use  in  daytime
          chemotherapy  center  was  successfully  established.  This  system  enabled  the  mandatory  grouping  and  association  of  externally
          dispensed  intravenous  prescriptions  with  in-hospital  diluents,  full-process  verification  based  on  drug  traceability  codes,  intelligent
          monitoring  of  infusion  parameters,  and  whole-process  data  traceability.  CONCLUSIONS  The  constructed  model  effectively
          resolves  the  coordination  and  safety  oversight  during  the  use  of  externally  dispensed  intravenous  drugs  from  out-of-hospital
          circulation to in-hospital use, and has preliminarily enabled procedural standardization, whole-process information traceability, and
                                                              proactive control of medication risks.
              Δ 基金项目 国家卫生健康委医院管理研究所医疗质量(循证)管
          理研究项目(No.YLZLXZ23K004)                              KEYWORDS    externally  dispensed  intravenous  prescriptions;
             *第一作者 副主任药师,硕士。研究方向:医院药学、药事管理。                   PIVAS;  closed-loop  management;  daytime  chemotherapy;
          E-mail:125923075@qq.com                             dual-channel policy
              # 通信作者 主任药师,硕士生导师,博士。研究方向:循证药学、
          数据挖掘与处理。E-mail:277749097@qq.com


          · 1246 ·    China Pharmacy  2026 Vol. 37  No. 10                            中国药房  2026年第37卷第10期
   7   8   9   10   11   12   13   14   15   16   17